Perelel
PrivateLast Round
Series A
Extension
Nov 20, 2025
Est. Valuation
$145M
Total Funding Raised
$37.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Perelel is a femtech company that provides doctor-formulated vitamin supplements for women's reproductive and hormonal health.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Subscription Commerce, Sports & Fitness, E-commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perelel Comparables
Compare Perelel with similar companies based on industry and business-model similarity.
Perelel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 20, 2025 | ||||
| Series A | Feb 1, 2024 | ||||
| Seed | Jul 19, 2022 |
Key People
Founding team and executive leadership
Perelel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Selva Ventures | Series A Extension, Series A |
| Prelude Growth Partners | Series A Extension |
| Willow Growth Partners | Series A Extension, Seed, Series A |
| Unilever Ventures | Series A Extension, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 129% MoM, reaching 629.6K.
- Jul 18, 2026
Grew 19% QoQ, from 43 to 51 employees.
Recent news
Latest coverage and updates
- partners_withOct 1, 2026
Perelel, Inc. partners with Coterie, Inc. on a limited-edition bundle, with more than 75 kits ready to ship the same day as launch and the collaboration selling out within 72 hours.
- has_revenueSep 29, 2026
Perelel, Inc. had revenue of $100M on Aug 1st '24.
- launchesSep 12, 2026
Perelel, Inc. launched Triple-Support Protein on Sep 10th '26.
- partners_withSep 10, 2026
Perelel, Inc. partnered with Bluestone Lane on Sep 10th '26.
Perelel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Perelel's valuation, stock price, and market status.
Is Perelel a public or private company?
Perelel is a private company.
What is the current stock price of Perelel?
Perelel is a private company, so its shares have no public market price. Caplight tracks Perelel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Perelel worth (valuation)?
Perelel's valuation is estimated at $145.0M based on funding round data.
Can I buy Perelel stock?
Perelel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Perelel's last funding round?
Perelel's most recent funding round was Series A Extension on November 20, 2025.
Who are the main investors in Perelel?
Key investors in Perelel include Selva Ventures, Prelude Growth Partners, Willow Growth Partners, Unilever Ventures.
Will Perelel IPO soon?
No public IPO plans have been announced for Perelel.
How can I track Perelel secondary market activity?
Caplight tracks bids, offers, and trades in Perelel's shares on secondary markets.